Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Eagle Pharmaceutical (EGRX)

58.73 1.21 (2.1%)

12-13 16:00

Open:

57.44

Pre. Close:

57.52

High:

58.9

Low:

57.05

Volume:

171,226

Market Cap:

876M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

59.6 - 61.02

61.02 - 61.97

Low:

54.4 - 55.62

55.62 - 56.44

Close:

57.24 - 59.35

59.35 - 60.76

Technical analysis  (as of: 2017-12-13 5:02:41 PM)

Overall:

      

Stoxline posted a NEUTRAL today, upgraded from lower rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next BUY or SELL signal.

Target:

Six months: 74.37     One year: 86.86

Support:

Support1: 56.84    Support2: 52.62

Resistance:

Resistance1: 63.67    Resistance2: 74.37

Pivot:

58.09

Moving Averages:

MA(5): 58.32     MA(20): 57.78

MA(100): 55.54     MA(250): 69.00

MACD:

MACD(12,26): 0.80     Signal(12,26,9): 0.84

%K %D:

%K(14,3): 50.74     %D(3): 49.13

RSI:

RSI(14): 54.68

52-Week:

High: 97.15  Low: 45.05  Change(%): -21.5

Average Vol(K):

3-Month: 27484  10-Days 22846

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
EGRX has closed below upper band by 37.2%. Bollinger Bands are 59.8% narrower than normal. The narrow width of the bands suggests low volatility as compared to EGRX's normal range. The bands have been in this narrow range for 25 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Thu, 07 Dec 2017 12:56:13 GMT
Eagle Pharmaceuticals commences pivotal study for Fulvestrant

Mon, 30 Oct 2017 20:26:15 GMT
Eagle Pharmaceuticals, Inc. to Discuss Third Quarter 2017 Financial Results on ...

Tue, 07 Nov 2017 21:22:30 GMT
Eagle Pharmaceuticals, Inc. to Present at Jefferies 2017 London Healthcare ...

Mon, 31 Jul 2017 10:41:15 GMT
Eagle Pharmaceuticals, Inc. to Present at 29th Annual Piper Jaffray Healthcare ...

Fri, 07 Jul 2017 15:11:15 GMT
Eagle Pharmaceuticals' Upcoming Catalysts Provide Support For Medium-Term Play

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Specialty Advanced Pharmaceuticals

Shares Out. (M)

14.92

Shares Float (M)

11.29

% Held by Insiders

11.72

% Held by Institutions

110.13

Shares Short (K)

3700

Shares Short Prior Month (K)

3890

Stock Financials

EPS

6.240

EPS Est. Current Year

3.790

EPS Est. Next Year

4.400

EPS Est. Next Quarter

1.050

Forward EPS

4.370

Book Value (p.s.)

11.470

PEG Ratio

0.88

Profit Margin

36.95

Operating Margin

34.86

Return on Assets (ttm)

28.6

Return on Equity (ttm)

72.4

Qtrly Rev. Growth

66.6

Gross Profit (p.s.)

8.993

Sales Per Share

EBITDA (p.s.)

6.552

Qtrly Earnings Growth

29.10

Operating Cash Flow (M)

72.55

Levered Free Cash Flow (M)

41.98

atoplab.com

Valuation

P/E

9.41

P/E Growth Ratio

0.02

P/BV

5.12

P/S

49144788.00

P/CF

12.08

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.